Skip to content
Search

Latest Stories

Impact of temporary pharmacy closures on patients: PDA submits evidence to PAC inquiry

Impact of temporary pharmacy closures on patients: PDA submits evidence to PAC inquiry

Escalating pharmacy closures forcing patients, who are being treated for addiction to illegal substances, to turn to the illegal market, warns PDA. 

The Pharmacists' Defence Association (PDA) recently provided written evidence to the Public Accounts Committee (PAC) inquiry on reducing the harm from illegal drugs, specifically highlighting the impact of temporary pharmacy closures on patients.


As defined by the association, a temporary closure is “where the pharmacy business, despite being contracted to the NHS to be open and to provide services to the public decides instead to close the pharmacy for partial days or one or more consecutive full days.”

This creates a barrier for patients to access treatment supporting their recovery from the use of illegal drugs, it said.

The PDA drew the Committee’s attention to the failure of the health departments to address the issue of temporary pharmacy closures, which has escalated significantly in the recent past.

As evidence, the PDA provided the Committee with published information along with data obtained by the association from Freedom of Information requests that showed the wide scale and GB-wide nature of temporary pharmacy closures.

Responding to the inquiry, the PDA also outlined the role of pharmacists in helping patients being treated for addiction to illegal substances, including the supply of controlled drugs such as methadone.

“The supply of methadone from pharmacies, which is personally supervised by a pharmacist, ensures that these vulnerable patients have access to safe and legal medicines as a substitute to illegally obtained opioids,” the PDA said.

The association added that even the smallest disruption in accessing the treatment can force vulnerable patients to turn to the illegal market with all the consequential risks.

Hence, it concluded that the issue of temporary pharmacy closures and the wider issue of permanent pharmacy closures “must be considered” when patients are being supported to withdraw from buying drugs on the illegal market.

The PAC accepted and published 22 written submissions in their call for evidence on these issues, including the evidence submitted by the PDA.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less